Infliximab therapy in ocular manifestations of behcet's disease / Sherif Ahmed Shawky ; Supervised Ayman Elgarf , Amira Abdelsaboor Shahin

By:

Sherif Ahmed Shawky

Contributor(s):

Material type: Text

TextLanguage: English Publication details: Cairo : Sherif Ahmed Shawky , 2012Description: 135P. : charts , facsimiles ; 25cmOther title:

تأثير عقار الأنفليكسيماب على أمراض العين المصاحبة لمرض بهجت [Added title page title]

Subject(s):

Available additional physical forms:

Issued also as CD

Dissertation note: Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilition Summary: This study was designed to assess the efficacy and safety of Infliximab (IFX) in the treatment of ocular manifestation in patients with Behcet's disease , namely BD-associated refractory posterior uveitis (PU) as expressed by VA improvement from baseline and to investigate the efficaey of IFX to reduce disease flare-up , to assess the proportion of relapse free subjects at the end of follow-up and the pereentage of patients achieving a complete or partial remission and to evaluate the tolerability and safety of the treatment

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Home library	Call number	Copy number	Status	Date due	Barcode
Thesis	قاعة الرسائل الجامعية - الدور الاول	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.Ph.D.2012.Sh.I (Browse shelf(Opens below))		Not for loan		01010110058959000
CD - Rom	مخـــزن الرســائل الجـــامعية - البدروم	المكتبة المركزبة الجديدة - جامعة القاهرة	Cai01.11.32.Ph.D.2012.Sh.I (Browse shelf(Opens below))	58959.CD	Not for loan		01020110058959000

Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	Cai01.11.32.Ph.D.2012.Ma.A Adrenomedullin-a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus /	Cai01.11.32.Ph.D.2012.Ma.U Urinary tweak; a biomarker for lupus nephritis activity /	Cai01.11.32.Ph.D.2012.Ma.U Urinary tweak; a biomarker for lupus nephritis activity /	Cai01.11.32.Ph.D.2012.Sh.I Infliximab therapy in ocular manifestations of behcet's disease /	Cai01.11.32.Ph.D.2012.Sh.I Infliximab therapy in ocular manifestations of behcet's disease /	Cai01.11.32.Ph.D.2013.Ba.M Myocardial function in behcet's disease assessment and correlation with disease parameters /	Cai01.11.32.Ph.D.2013.Ba.M Myocardial function in behcet's disease assessment and correlation with disease parameters /	Next

Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilition

This study was designed to assess the efficacy and safety of Infliximab (IFX) in the treatment of ocular manifestation in patients with Behcet's disease , namely BD-associated refractory posterior uveitis (PU) as expressed by VA improvement from baseline and to investigate the efficaey of IFX to reduce disease flare-up , to assess the proportion of relapse free subjects at the end of follow-up and the pereentage of patients achieving a complete or partial remission and to evaluate the tolerability and safety of the treatment

Issued also as CD

There are no comments on this title.

to post a comment.